Probing substrate binding to Metallo-β-Lactamase L1 from Stenotrophomonas maltophilia by using site-directed mutagenesis

BackgroundThe metallo-β-lactamases are Zn(II)-containing enzymes that hydrolyze the β-lactam bond in penicillins, cephalosporins, and carbapenems and are involved in bacterial antibiotic resistance. There are at least 20 distinct organisms that produce a metallo-β-lactamase, and these enzymes have been extensively studied using X-ray crystallographic, computational, kinetic, and inhibition studies; however, much is still unknown about how substrates bind and the catalytic mechanism. In an effort to probe substrate binding to metallo-β-lactamase L1 from Stenotrophomonas maltophilia, nine site-directed mutants of L1 were prepared and characterized using metal analyses, CD spectroscopy, and pre-steady state and steady state kinetics.ResultsSite-directed mutations were generated of amino acids previously predicted to be important in substrate binding. Steady-state kinetic studies using the mutant enzymes and 9 different substrates demonstrated varying Km and kcat values for the different enzymes and substrates and that no direct correlation between Km and the effect of the mutation on substrate binding could be drawn. Stopped-flow fluorescence studies using nitrocefin as the substrate showed that only the S224D and Y228A mutants exhibited weaker nitrocefin binding.ConclusionsThe data presented herein indicate that Ser224, Ile164, Phe158, Tyr228, and Asn233 are not essential for tight binding of substrate to metallo-β-lactamase L1. The results in this work also show that Km values are not reliable for showing substrate binding, and there is no correlation between substrate binding and the amount of reaction intermediate formed during the reaction. This work represents the first experimental testing of one of the computational models of the metallo-β-lactamases.

[1]  D. Payne,et al.  Inhibition of metallo-beta-lactamases by a series of mercaptoacetic acid thiol ester derivatives , 1997, Antimicrobial agents and chemotherapy.

[2]  S. Levy,et al.  The challenge of antibiotic resistance. , 1998, Scientific American.

[3]  B. Sutton,et al.  Crystal structure of the zinc-dependent beta-lactamase from Bacillus cereus at 1.9 A resolution: binuclear active site with features of a mononuclear enzyme. , 1998, Biochemistry.

[4]  A. Carfi The 3-D structure of a zinc metallo-β-lactarnase from Bacillus cereus reveals a new type of protein fold , 1995 .

[5]  D. Payne,et al.  Inhibition of metallo-beta-lactamases by a series of thiol ester derivatives of mercaptophenylacetic acid. , 1997, FEMS microbiology letters.

[6]  G. Eliopoulos,et al.  New beta-lactamases in gram-negative bacteria: diversity and impact on the selection of antimicrobial therapy. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  J. Frère,et al.  Interaction between class B β‐lactamases and suicide substrates of active‐site serine β‐lactamases , 1999 .

[8]  Moreno Galleni,et al.  Standard Numbering Scheme for Class B β-Lactamases , 2001, Antimicrobial Agents and Chemotherapy.

[9]  G. Wright,et al.  Resisting resistance: new chemical strategies for battling superbugs. , 2000, Chemistry & biology.

[10]  Cricco Ja,et al.  Class B beta-lactamases: the importance of being metallic. , 1999 .

[11]  J. Frère,et al.  Purification, crystallization and preliminary X-ray analysis of Bacteroides fragilis Zn2+ beta-lactamase. , 1997, Acta crystallographica. Section D, Biological crystallography.

[12]  R. Ambler,et al.  The structure of beta-lactamases. , 1980, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[13]  L. Rice,et al.  β -Lactamases: which ones are clinically important? , 2000 .

[14]  M. Gilpin,et al.  Isolation and structure determination of two novel phenazines from a Streptomyces with inhibitory activity against metallo-enzymes, including metallo-β-lactamase , 1995 .

[15]  K. Bush,et al.  Carbapenem-hydrolyzing beta-lactamases , 1997, Antimicrobial agents and chemotherapy.

[16]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[17]  I. Taylor,et al.  The crystal structure of the L1 metallo-beta-lactamase from Stenotrophomonas maltophilia at 1.7 A resolution. , 1998, Journal of molecular biology.

[18]  J. Burke,et al.  Risk Factors for Epidemic Xanthomonas Maltophilia Infection/Colonization in Intensive Care Unit Patients , 1992, Infection Control & Hospital Epidemiology.

[19]  B. Schable,et al.  Nosocomial infections due to Xanthomonas maltophilia (Pseudomonas maltophilia) in patients with cancer. , 1990, Reviews of infectious diseases.

[20]  C. Makaroff,et al.  Arabidopsis Glyoxalase II Contains a Zinc/Iron Binuclear Metal Center That Is Essential for Substrate Binding and Catalysis* 210 , 2001, The Journal of Biological Chemistry.

[21]  C. Brooks,et al.  Modeling of the metallo‐β‐lactamase from B. fragilis: Structural and dynamic effects of inhibitor binding , 2001, Proteins.

[22]  P. Fitzgerald,et al.  Unanticipated inhibition of the metallo-beta-lactamase from Bacteroides fragilis by 4-morpholineethanesulfonic acid (MES): a crystallographic study at 1.85-A resolution. , 1998, Biochemistry.

[23]  J. Burke,et al.  Risk factors for epidemic Xanthomonas maltophilia infection/colonization in intensive care unit patients. , 1992 .

[24]  J. Williams,et al.  -Lactamases and -lactamase inhibitors , 1999 .

[25]  D. Vanderwall,et al.  Antibiotic sensitization using biphenyl tetrazoles as potent inhibitors of Bacteroides fragilis metallo-beta-lactamase. , 1998, Chemistry & biology.

[26]  C. Pace,et al.  How to measure and predict the molar absorption coefficient of a protein , 1995, Protein science : a publication of the Protein Society.

[27]  D. Payne,et al.  beta-lactamase epidemiology and the utility of established and novel beta-lactamase inhibitors , 2000, Expert opinion on investigational drugs.

[28]  K. Bush Characterization of beta-lactamases , 1989, Antimicrobial Agents and Chemotherapy.

[29]  H. Mett,et al.  Outer membrane permeability and beta-lactamase content in Pseudomonas maltophilia clinical isolates and laboratory mutants. , 1988, Reviews of infectious diseases.

[30]  J. Frère,et al.  Crystal structure of the IMP-1 metallo beta-lactamase from Pseudomonas aeruginosa and its complex with a mercaptocarboxylate inhibitor: binding determinants of a potent, broad-spectrum inhibitor. , 2000, Biochemistry.

[31]  D. Vanderwall,et al.  Structure-activity relationships of biphenyl tetrazoles as metallo-β-lactamase inhibitors , 1999 .

[32]  M. Crowder,et al.  Inhibition studies on the metallo-beta-lactamase L1 from Stenotrophomonas maltophilia. , 1999, Archives of biochemistry and biophysics.

[33]  Gopal R Periyannan,et al.  The problem of a solvent exposable disulfide when preparing Co(II)-substituted metallo-β-lactamase L1 from Stenotrophomonas maltophilia , 2000, JBIC Journal of Biological Inorganic Chemistry.

[34]  T. Walsh,et al.  Overexpression, Purification, and Characterization of the Cloned Metallo-β-Lactamase L1 fromStenotrophomonas maltophilia , 1998, Antimicrobial Agents and Chemotherapy.

[35]  Rie Nagano,et al.  Carbapenem Derivatives as Potential Inhibitors of Various β-Lactamases, Including Class B Metallo-β-Lactamases , 1999, Antimicrobial Agents and Chemotherapy.

[36]  M. Crowder,et al.  Kinetic mechanism of metallo-beta-lactamase L1 from Stenotrophomonas maltophilia. , 1999, Biochemistry.

[37]  N. Sharma,et al.  Succinic Acids as Potent Inhibitors of Plasmid-borne IMP-1 Metallo-β-lactamase* , 2001, The Journal of Biological Chemistry.

[38]  M. Page The Mechanisms of Reactions of β-Lactam Antibiotics , 1984 .

[39]  O. Herzberg,et al.  Crystal structure of the wide-spectrum binuclear zinc β-lactamase from Bacteroides fragilis , 1996 .

[40]  Stephen J. Benkovic,et al.  Metallo-β-lactamase: structure and mechanism , 1999 .

[41]  E. Ceccarelli,et al.  Metallo-β-lactamases: does it take two to tango? , 1999 .

[42]  K. Bush,et al.  Classification of beta-lactamases: groups 2c, 2d, 2e, 3, and 4 , 1989, Antimicrobial Agents and Chemotherapy.

[43]  O. Herzberg,et al.  Crystal structures of the cadmium‐ and mercury‐substituted metallo‐β‐lactamase from Bacteroides fragilis , 1997, Protein science : a publication of the Protein Society.

[44]  Timothy R. Walsh,et al.  Sequence analysis of the L1 metallo-β-lactamase from Xanthomonas maltophilia , 1994 .

[45]  M. Galleni,et al.  Interactions of biapenem with active-site serine and metallo-beta-lactamases , 1995, Antimicrobial agents and chemotherapy.

[46]  Bernstein Nj,et al.  On the importance of a methyl group in beta-lactamase evolution: free energy profiles and molecular modeling. , 1999 .

[47]  B. Shoichet,et al.  Energetic, structural, and antimicrobial analyses of beta-lactam side chain recognition by beta-lactamases. , 2001, Chemistry & biology.

[48]  J. Knowles Penicillin resistance: the chemistry of .beta.-lactamase inhibition , 1985 .

[49]  W C Johnson,et al.  Analysis of protein circular dichroism spectra for secondary structure using a simple matrix multiplication. , 1986, Analytical biochemistry.

[50]  S. Mobashery,et al.  Critical hydrogen bonding by serine 235 for cephalosporinase activity of TEM-1 beta-lactamase , 1993, Antimicrobial Agents and Chemotherapy.

[51]  S. Mobashery,et al.  Elucidation of the role of arginine-244 in the turnover processes of class A beta-lactamases. , 1992, Biochemistry.

[52]  K. Bush,et al.  How β-Lactamases Have Driven Pharmaceutical Drug Discovery , 1998 .

[53]  K. Bush,et al.  Metallo-β-Lactamases: A Class Apart , 1998 .

[54]  S. Ho,et al.  Site-directed mutagenesis by overlap extension using the polymerase chain reaction. , 1989, Gene.

[55]  Dimas Suárez,et al.  Zinc Metallo-β-Lactamase from Bacteroides fragilis: A Quantum Chemical Study on Model Systems of the Active Site , 2000 .

[56]  H. Dyson,et al.  NMR characterization of the metallo-beta-lactamase from Bacteroides fragilis and its interaction with a tight-binding inhibitor: role of an active-site loop. , 1999, Biochemistry.

[57]  K. Bush,et al.  Classification of beta-lactamases: groups 1, 2a, 2b, and 2b' , 1989, Antimicrobial Agents and Chemotherapy.

[58]  Y. Arakawa,et al.  Convenient Test for Screening Metallo-β-Lactamase-Producing Gram-Negative Bacteria by Using Thiol Compounds , 2000, Journal of Clinical Microbiology.

[59]  K M Merz,et al.  Molecular dynamics simulations of the mononuclear zinc-beta-lactamase from Bacillus cereus. , 2001, Journal of the American Chemical Society.

[60]  D. Payne,et al.  Metallo-beta-lactamases--a new therapeutic challenge. , 1993, Journal of medical microbiology.

[61]  V. Yu,et al.  Infections caused by Pseudomonas maltophilia. Expanding clinical spectrum. , 1987, Archives of internal medicine.

[62]  G. Jacoby,et al.  A functional classification scheme for beta-lactamases and its correlation with molecular structure , 1995, Antimicrobial agents and chemotherapy.

[63]  A. Peracchi,et al.  Enzyme catalysis: removing chemically 'essential' residues by site-directed mutagenesis. , 2001, Trends in biochemical sciences.

[64]  J. Frère,et al.  The beta-lactamase cycle: a tale of selective pressure and bacterial ingenuity. , 1999, Natural product reports.

[65]  A. Clarke,et al.  Novel Mechanism of Hydrolysis of Therapeutic β-Lactams byStenotrophomonas maltophilia L1 Metallo-β-lactamase* , 2001, The Journal of Biological Chemistry.

[66]  J. Frère,et al.  The 3‐D structure of a zinc metallo‐beta‐lactamase from Bacillus cereus reveals a new type of protein fold. , 1995 .

[67]  M. Crowder,et al.  Mutational Analysis of Metallo-β-lactamase CcrA from Bacteroides fragilis† , 2000 .

[68]  M. Page,et al.  The mechanisms of reactions of .beta.-lactam antibiotics , 1984 .